Investor Information

Investing in a cancer therapy to target all solid tumours

LIfT’s existing investors include Jonathan Milner (Meltwind & Abcam), Kizoo Technology Ventures, Starbloom Capital and Downing Ventures. LIfT has raised $10m to date and has a $30m Series A planned for early 2023 with two major pharma funds.

 

We are interested in investors joining the syndicate who personally share our mission objective to develop a cure for all solid tumours, and who can make a positive contribution to the future direction of the company. If you would be interested in joining the $5m+ ticket size round please contact us.

Lift-Biosciences-Labs-Teresa-Walton-Photography-Web-34.jpg

Proudly Supported by / Partnered with: